Sub-Tenon triamcinolone is one of 2 small molecule programs targeting Macular Edema. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2 competitors in Macular Edema
CU06-1004
Sub-Tenon triamcinolone
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources